Kymera Therapeutics Pivots to Immunology, Highlights KT-621 Data, Starts IRF5 Dosing; Runway to 2029
Kymera Therapeutics (NASDAQ:KYMR) executives highlighted a sharpened strategic focus on immunology and inflammation at ...
The Pilot Immunology Study provides a framework to assess the regulation and temporal changes in host immune responses during standard short course anti-TB chemotherapy in culture-confirmed pulmonary ...
Real-world data from 2016 to 2025 highlight the changing landscape of biologic use and the growing preference for tezepelumab in asthma.
HOUSTON -- Researchers at The University of Texas MD Anderson Cancer Center have discovered that a protein called NF-kappa B-inducing kinase (NIK) is essential for the shift in metabolic activity that ...
The data suggest significant challenges in maintaining long-term disease control with advanced systemic therapies for atopic dermatitis.
AbbVie Inc. (NYSE:ABBV), included in the Russell 1000, remains a prominent name across widely followed market indices. Recent ...
Age could be a dominant factor in influencing antibody production in response to a virus -- for a given virus, certain antibodies increase with age while others decrease, depending on which part of ...
SAN CARLOS, Calif.--(BUSINESS WIRE)--IncellDx, a precision medicine company, today announced the journal Frontiers in Immunology has published a study detailing a framework for understanding the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results